The dexamethasone suppression test. An indicator of depression in stroke but not a predictor of rehabilitation outcome.
The dexamethasone suppression test (DST) result was found to be abnormal in 49% of patients who were an average of seven weeks post stroke. The DST response correlated with depressive symptoms as measured by both the Zung and modified Hamilton Depression scales. The specificity of the DST for clinically diagnosed depression reached 87% for the 8 AM cortisol determination, with a corresponding sensitivity of 47%. It was not related to the patient's final level of self-care function as measured by the Barthel score, need for nursing home placement following discharge, or duration of rehabilitation needed to achieve maximum benefit. Abnormal responses were more prevalent in cerebral hemisphere than in brain-stem or cerebellar strokes. The more extensive the stroke the more likely the possibility of an abnormal DST response. The DST response is stable, with test-retest replicability being 84% at two weeks and 74% at seven weeks.
D002561:Cerebrovascular Disorders / Q000150:complications / Q000175:diagnosis*; D003863:Depression / Q000175:diagnosis* / Q000209:etiology; D003907:Dexamethasone; D006801:Humans; D006854:Hydrocortisone / Q000097:blood
D003907:Dexamethasone; D006854:Hydrocortisone